Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease: The Randomized Controlled Lp(a)FRONTIERS EXPANSION Study

Keith C. Ferdinand, Fatima Rodriguez, Duccio Baldari, James Sullivan, Alexis Gutierrez, Subha Venkataraman, Kenny Onate-Quiroz, Hui Cao, Wenyue Zhu, Jing Wang, Michael D. Shapiro

Open source

DOI: 10.1161/circoutcomes.126.014453
Published: 2026-11-09
Container: Circulation: Population Health and Outcomes
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1161/circoutcomes.126.014453,
  title = {Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease: The Randomized Controlled Lp(a)FRONTIERS EXPANSION Study},
  author = {Keith C. Ferdinand and Fatima Rodriguez and Duccio Baldari and James Sullivan and Alexis Gutierrez and Subha Venkataraman and Kenny Onate-Quiroz and Hui Cao and Wenyue Zhu and Jing Wang and Michael D. Shapiro},
  year = {2026},
  journal = {Circulation: Population Health and Outcomes},
  doi = {10.1161/circoutcomes.126.014453},
  url = {https://doi.org/10.1161/circoutcomes.126.014453}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease: The Randomized Controlled Lp(a)FRONTIERS EXPANSION Study
AU  - Keith C. Ferdinand
AU  - Fatima Rodriguez
AU  - Duccio Baldari
AU  - James Sullivan
AU  - Alexis Gutierrez
AU  - Subha Venkataraman
AU  - Kenny Onate-Quiroz
AU  - Hui Cao
AU  - Wenyue Zhu
AU  - Jing Wang
AU  - Michael D. Shapiro
PY  - 2026
JO  - Circulation: Population Health and Outcomes
DO  - 10.1161/circoutcomes.126.014453
UR  - https://doi.org/10.1161/circoutcomes.126.014453
ER  -

APA

Ferdinand, K. C., Rodriguez, F., Baldari, D., Sullivan, J., Gutierrez, A., Venkataraman, S., Onate-Quiroz, K., Cao, H., Zhu, W., Wang, J., & Shapiro, M. D. (2026). Efficacy and Safety of Pelacarsen in Black/African American and Hispanic Participants with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease: The Randomized Controlled Lp(a)FRONTIERS EXPANSION Study. Circulation: Population Health and Outcomes. https://doi.org/10.1161/circoutcomes.126.014453

Source records

crossref · retrieved 2026-11-10T10:29:10.072Z